Showing results (111-120 of 152) with videos related to

Sort By:
Pageof 16
Reports of Biochemistry & Molecular Biology|May 3, 2023
Evaluation of IGF2, KRT14, and KRT20 as Urinary Biomarkers in Patients with Bladder CancerAzam Rasti, Masoud Khalili, Ali Mohammad Fakhr Yasseri, et al.
Scientific Reports|February 10, 2022
Antiproliferative effects of AAV-delivered CRISPR/Cas9-based degradation of the HPV18-E6 gene in HeLa cellsZahra Noroozi, Mehdi Shamsara, Elahe Valipour, et al.
Biomarker Research|December 19, 2024
mRNA cancer vaccines from bench to bedside: a new era in cancer immunotherapyAlireza Shariati, Pouria Khani, Farzad Nasri, et al.
Nanomedicine (London, England)|May 1, 2023
Using chitosan-stabilized, hyaluronic acid-modified selenium nanoparticles to deliver CD44-targeted PLK1 siRNAs for treating bladder cancerMaryamsadat Shahidi, Omid Abazari, Parisa Dayati, et al.
Frontiers in Immunology|January 28, 2025
DNA vaccines as promising immuno-therapeutics against cancer: a new insightAlireza Shariati, Arya Khezrpour, Fatemeh Shariati, et al.
Pathology, Research and Practice|August 23, 2021
New evidence on tumor suppressor activity of PTEN and KLLN in papillary thyroid carcinomaS Adeleh Razavi, Pouya Salehipour, Hanieh Gholami, et al.
Pathology Oncology Research : POR|October 24, 2017
Cancer-Testis Antigens as New Candidate Diagnostic Biomarkers for Transitional Cell Carcinoma of BladderMandana Afsharpad, Mohammad Reza Nowroozi, Maryam Beigom Mobasheri, et al.
Iranian Biomedical Journal|September 4, 2017
ODF4, MAGEA3, and MAGEB4: Potential Biomarkers in Patients with Transitional Cell CarcinomaMandana Afsharpad, Mohammad Reza Nowroozi, Mohsen Ayati, et al.
Journal of Cellular Biochemistry|January 24, 2019
Construction of a chimeric antigen receptor bearing a nanobody against prostate a specific membrane antigen in prostate cancerMahmoud Hassani, Fatemeh Hajari Taheri, Zahra Sharifzadeh, et al.
Pageof 16